These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22520930)

  • 1. From the editor.
    Weinberger MH
    J Am Soc Hypertens; 2012; 6(3):161-2. PubMed ID: 22520930
    [No Abstract]   [Full Text] [Related]  

  • 2. Where do we go from here?
    Pearson TA
    Am J Med; 2008 Oct; 121(10 Suppl 1):S32-4. PubMed ID: 18926168
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular risk in kidney transplant recipients with diabetes].
    Biancone L
    G Ital Nefrol; 2010; 27(1):5. PubMed ID: 20191451
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES).
    Balducci S; Zanuso S; Nicolucci A; De Feo P; Cavallo S; Cardelli P; Fallucca S; Alessi E; Fallucca F; Pugliese G;
    Arch Intern Med; 2010 Nov; 170(20):1794-803. PubMed ID: 21059972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved knowledge of antidiabetic treatment--a necessity for the modern cardiologist.
    Wikström G; Malmberg K; Rydén L
    Eur Heart J; 1999 Mar; 20(6):403-5. PubMed ID: 10213343
    [No Abstract]   [Full Text] [Related]  

  • 7. Legacy effect in medicine-the expanding horizon!
    Wander GS; Bansal M
    Indian Heart J; 2018; 70(6):769-771. PubMed ID: 30580842
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes: one part of the cardiovascular problem post-transplant.
    Luxon A; First MR
    Nephrol News Issues; 2006 Sep; 20(10):33-4. PubMed ID: 16977919
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Schindhelm RK; Heine RJ; Diamant M
    Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
    [No Abstract]   [Full Text] [Related]  

  • 10. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Davis TM
    Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's cardiovascular health: prevention is key.
    Oertelt-Prigione S; Regitz-Zagrosek V
    Arch Intern Med; 2009 Oct; 169(19):1740-1. PubMed ID: 19858428
    [No Abstract]   [Full Text] [Related]  

  • 12. Health epidemics on tribal lands.
    Davis S
    NCSL Legisbrief; 2006; 14(26):1-2. PubMed ID: 16761342
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifiable risk factors in midlife and the age of onset of diabetes mellitus: a 34-year follow-up study.
    Pienimäki T; Strandberg AY; Pitkälä KH; Tilvis RS; Miettinen TA; Salomaa V; Strandberg TE
    J Am Geriatr Soc; 2012 Jan; 60(1):174-6. PubMed ID: 22239309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes, a public health problem. The epidemiology of sugar diabetes and its long term complications].
    Ekoé JM; Emond V; Huot C
    Perspect Infirm; 2006; 4(2):10-6. PubMed ID: 17184091
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology and risk factors of macrovascular disease in diabetes mellitus.
    Janka HU
    Horm Metab Res Suppl; 1990; 22():8-11. PubMed ID: 2202634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neglected diseases in cardiology: a call for urgent action.
    Yacoub S; Kotit S; Mocumbi AO; Yacoub MH
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):176-7. PubMed ID: 18317476
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
    Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
    Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.